![Janet Horton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Horton
Directeur Technique/Scientifique/R&D chez
AKTIS ONCOLOGY, INC.
Profil
Janet Horton is currently Vice President & Head-Clinical Development at Aktis Oncology, Inc. since 2022.
Formerly, Dr. Horton was Head-Program Management at Brii Biosciences, Inc. Dr. Horton completed undergraduate studies at the University of East London.
Postes actifs de Janet Horton
| Sociétés | Poste | Début |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | 01/08/2022 |
Anciens postes connus de Janet Horton
| Sociétés | Poste | Fin |
|---|---|---|
Brii Biosciences, Inc.
 Brii Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops therapies | Corporate Officer/Principal | - |
Formation de Janet Horton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of East London
 University of East London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Brii Biosciences, Inc.
Brii Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops therapies | Commercial Services |
